Puma Biotechnology, Inc.'s (NASDAQ:PBYI) US$24m market value fall may be overlooked by institutional investors after a year of 1.6% returns - Simply Wall St News
Former Puma Biotech Executive Gets U.S. Prison Term for Insider Trading
Puma Stock Jumps as Biotech Gets Good News From the FDA | Barron's
Puma Biotechnology Reports Fourth Quarter and Full Year Financial Results | Business Wire
Puma Biotechnology (PBYI) Stock Climbs On Orphan Drug Designation | Alpha Stock News
Puma Biotech agrees to pay investors $54.2 mln in fraud case | Reuters
Puma Biotech (PBYI) Stock up as Q2 Earnings & Sales Beat